Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes

Jin-Man Jung, Jaehyung Cha, Jungsoon Choi, Mi Yeon Eun, Woo Keun Seo, Kyungmi Oh, Kyung-Hee Cho, Sungwook Yu

Research output: Contribution to journalArticle

Abstract

Background: It is not well known whether prestroke antiplatelet agents (PAs) are associated with the subtypes of ischemic stroke. Methods: We screened patients in a hospital-based stroke registry. Patients who were admitted with a diagnosis of first-time ischemic stroke within 5 days of symptom onset were included. Ischemic stroke subtypes were classified in accordance with the Trial of ORG 10172 in Acute Stroke Treatment classification based on stroke mechanism: large-artery atherosclerosis (LA), cardioembolism (CE), small vessel occlusion (SVO), other determined (OC) or undetermined causes (UC). Multinomial logistic regression analyses were performed to evaluate the effect of PA on stroke subtypes before and after propensity score matching. Results: Among 3,025 patients, 748 (24.7%) were taking antiplatelet agents prior to stroke. After propensity score matching, 1,190 patients were ultimately included. The PA group was associated with strokes caused by SVO rather than LA in multinomial logistic regression of an unmatched dataset. However, multivariable analysis after propensity score matching demonstrated that PA use was associated with a higher probability of SVO and CE (OR 2.05, p < 0.001 and OR 1.62, p = 0.05, respectively) compared with LA. Conclusions: PAs were associated with specific index stroke subtypes.

Original languageEnglish
Pages (from-to)89-95
Number of pages7
JournalEuropean Neurology
Volume75
Issue number1-2
DOIs
Publication statusPublished - 2016 Mar 1

Fingerprint

Platelet Aggregation Inhibitors
Stroke
Propensity Score
Atherosclerosis
Arteries
Logistic Models
Registries
Regression Analysis

Keywords

  • Ischemic stroke
  • Prestroke antiplatelet agents
  • Subtypes

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes. / Jung, Jin-Man; Cha, Jaehyung; Choi, Jungsoon; Eun, Mi Yeon; Seo, Woo Keun; Oh, Kyungmi; Cho, Kyung-Hee; Yu, Sungwook.

In: European Neurology, Vol. 75, No. 1-2, 01.03.2016, p. 89-95.

Research output: Contribution to journalArticle

Jung, Jin-Man ; Cha, Jaehyung ; Choi, Jungsoon ; Eun, Mi Yeon ; Seo, Woo Keun ; Oh, Kyungmi ; Cho, Kyung-Hee ; Yu, Sungwook. / Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes. In: European Neurology. 2016 ; Vol. 75, No. 1-2. pp. 89-95.
@article{78b15beb84e442c89b5fe33e744d36f1,
title = "Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes",
abstract = "Background: It is not well known whether prestroke antiplatelet agents (PAs) are associated with the subtypes of ischemic stroke. Methods: We screened patients in a hospital-based stroke registry. Patients who were admitted with a diagnosis of first-time ischemic stroke within 5 days of symptom onset were included. Ischemic stroke subtypes were classified in accordance with the Trial of ORG 10172 in Acute Stroke Treatment classification based on stroke mechanism: large-artery atherosclerosis (LA), cardioembolism (CE), small vessel occlusion (SVO), other determined (OC) or undetermined causes (UC). Multinomial logistic regression analyses were performed to evaluate the effect of PA on stroke subtypes before and after propensity score matching. Results: Among 3,025 patients, 748 (24.7{\%}) were taking antiplatelet agents prior to stroke. After propensity score matching, 1,190 patients were ultimately included. The PA group was associated with strokes caused by SVO rather than LA in multinomial logistic regression of an unmatched dataset. However, multivariable analysis after propensity score matching demonstrated that PA use was associated with a higher probability of SVO and CE (OR 2.05, p < 0.001 and OR 1.62, p = 0.05, respectively) compared with LA. Conclusions: PAs were associated with specific index stroke subtypes.",
keywords = "Ischemic stroke, Prestroke antiplatelet agents, Subtypes",
author = "Jin-Man Jung and Jaehyung Cha and Jungsoon Choi and Eun, {Mi Yeon} and Seo, {Woo Keun} and Kyungmi Oh and Kyung-Hee Cho and Sungwook Yu",
year = "2016",
month = "3",
day = "1",
doi = "10.1159/000444295",
language = "English",
volume = "75",
pages = "89--95",
journal = "European Neurology",
issn = "0014-3022",
publisher = "S. Karger AG",
number = "1-2",

}

TY - JOUR

T1 - Prestroke Antiplatelet Agents in First-Time Ischemic Stroke Are Related to Subtypes

AU - Jung, Jin-Man

AU - Cha, Jaehyung

AU - Choi, Jungsoon

AU - Eun, Mi Yeon

AU - Seo, Woo Keun

AU - Oh, Kyungmi

AU - Cho, Kyung-Hee

AU - Yu, Sungwook

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Background: It is not well known whether prestroke antiplatelet agents (PAs) are associated with the subtypes of ischemic stroke. Methods: We screened patients in a hospital-based stroke registry. Patients who were admitted with a diagnosis of first-time ischemic stroke within 5 days of symptom onset were included. Ischemic stroke subtypes were classified in accordance with the Trial of ORG 10172 in Acute Stroke Treatment classification based on stroke mechanism: large-artery atherosclerosis (LA), cardioembolism (CE), small vessel occlusion (SVO), other determined (OC) or undetermined causes (UC). Multinomial logistic regression analyses were performed to evaluate the effect of PA on stroke subtypes before and after propensity score matching. Results: Among 3,025 patients, 748 (24.7%) were taking antiplatelet agents prior to stroke. After propensity score matching, 1,190 patients were ultimately included. The PA group was associated with strokes caused by SVO rather than LA in multinomial logistic regression of an unmatched dataset. However, multivariable analysis after propensity score matching demonstrated that PA use was associated with a higher probability of SVO and CE (OR 2.05, p < 0.001 and OR 1.62, p = 0.05, respectively) compared with LA. Conclusions: PAs were associated with specific index stroke subtypes.

AB - Background: It is not well known whether prestroke antiplatelet agents (PAs) are associated with the subtypes of ischemic stroke. Methods: We screened patients in a hospital-based stroke registry. Patients who were admitted with a diagnosis of first-time ischemic stroke within 5 days of symptom onset were included. Ischemic stroke subtypes were classified in accordance with the Trial of ORG 10172 in Acute Stroke Treatment classification based on stroke mechanism: large-artery atherosclerosis (LA), cardioembolism (CE), small vessel occlusion (SVO), other determined (OC) or undetermined causes (UC). Multinomial logistic regression analyses were performed to evaluate the effect of PA on stroke subtypes before and after propensity score matching. Results: Among 3,025 patients, 748 (24.7%) were taking antiplatelet agents prior to stroke. After propensity score matching, 1,190 patients were ultimately included. The PA group was associated with strokes caused by SVO rather than LA in multinomial logistic regression of an unmatched dataset. However, multivariable analysis after propensity score matching demonstrated that PA use was associated with a higher probability of SVO and CE (OR 2.05, p < 0.001 and OR 1.62, p = 0.05, respectively) compared with LA. Conclusions: PAs were associated with specific index stroke subtypes.

KW - Ischemic stroke

KW - Prestroke antiplatelet agents

KW - Subtypes

UR - http://www.scopus.com/inward/record.url?scp=84957882247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957882247&partnerID=8YFLogxK

U2 - 10.1159/000444295

DO - 10.1159/000444295

M3 - Article

VL - 75

SP - 89

EP - 95

JO - European Neurology

JF - European Neurology

SN - 0014-3022

IS - 1-2

ER -